Cipher Pharmaceuticals (CPH) Competitors

Cronos Group (TSE:CRON) and Cipher Pharmaceuticals (TSE:CPH) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, media sentiment, dividends, analyst recommendations and profitability.

Which has preferable valuation and earnings, CRON or CPH?

Cipher Pharmaceuticals has lower revenue, but higher earnings than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	C$76.86M	10.93	-C$32.78M	-C$0.18	-17.69
Cipher Pharmaceuticals	C$19.03M	14.53	C$11.41M	C$0.91	17.01

Do insiders & institutionals believe in CRON or CPH?

16.0% of Cronos Group shares are held by institutional investors. Comparatively, 1.4% of Cipher Pharmaceuticals shares are held by institutional investors. 46.4% of Cronos Group shares are held by company insiders. Comparatively, 42.0% of Cipher Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has more risk & volatility, CRON or CPH?

Cronos Group has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Comparatively, Cipher Pharmaceuticals has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500.

Does the media favor CRON or CPH?

In the previous week, Cronos Group and Cronos Group both had 1 articles in the media. Cronos Group's average media sentiment score of 0.00 equaled Cipher Pharmaceuticals'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cipher Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is CRON or CPH more profitable?

Cipher Pharmaceuticals has a net margin of 59.92% compared to Cronos Group's net margin of -42.65%. Cipher Pharmaceuticals' return on equity of 17.93% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-42.65%	-4.40%	-3.73%
Cipher Pharmaceuticals	59.92%	17.93%	7.90%

Do analysts prefer CRON or CPH?

Cipher Pharmaceuticals has a consensus price target of C$14.75, suggesting a potential downside of 4.22%. Given Cipher Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Cipher Pharmaceuticals is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cipher Pharmaceuticals	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

Summary

Cipher Pharmaceuticals beats Cronos Group on 12 of the 15 factors compared between the two stocks.